![]() |
![]() |
| Psychiatry Investig > Volume 23(6); 2026 > Article |
|
Availability of Data and Material
The data that support the findings of study are available from the corresponding author upon reasonable request.
Conflicts of Interest
Jae-Min Kim, a contributing editor of the Psychiatry Investigation, was not involved in the editorial evaluation or decision to publish this article. All remaining authors have declared no conflicts of interest.
Author Contributions
Conceptualization: Jae-Min Kim. Data curation: Jae-Min Kim, Hee-Ju Kang. Formal analysis: Hee-Ju Kang. Funding acquisition: Jae-Min Kim, Hee-Ju Kang. Investigation: Jae-Min Kim, Hee-Ju Kang. Methodology: Jae-Min Kim, Hee-Ju Kang, Ju-Wan Kim, Sung-Wan Kim. Project administration: Jae-Min Kim, Hee-Ju Kang, Ju-Wan Kim, Joon-Tae Kim, Man-Seok Park, Min-Chul Kim, Yougnkeun Ahn, Myung Ho Jeong. Resource: Jae-Min Kim. Software: Hee-Ju Kang. Supervision: all authors. Validation: Ju-Wan Kim, Sung-Wan Kim, Joon-Tae Kim, Man-Seok Park, Min-Chul Kim, Yougnkeun Ahn, Myung Ho Jeong. Writing—original draft: Hee-Ju Kang, Jae-Min Kim. Writing—review & editing: all authors.
Funding Statement
The study was funded by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (No. RS-2024-00440371) to Jae-Min Kim and by grant (BCRI-26077) of Chonnam National University Hospital Biomedical Research Institute to Hee-Ju Kang.
Acknowledgments
None
| Patients group | Long-term outcome |
Education level at baseline |
||
|---|---|---|---|---|
| Lower (≤10 years) (N=578) | Higher (>10 years) (N=574) | p | ||
| ACS | MACE | 267 (46.2) | 179 (31.2) | <0.001‡ |
| All-cause mortality | 138 (23.9) | 73 (12.7) | <0.001‡ | |
| Cardiac death | 70 (12.1) | 41 (7.1) | 0.004† | |
| Recurrent MI | 62 (10.7) | 48 (8.4) | 0.172 | |
| Recurrent percutaneous coronary intervention | 92 (15.9) | 70 (12.2) | 0.069 | |
| Lower (≤10 years) (N=247) | Higher (>10 years) (N=149) | p | ||
| Stroke | Cerebro-cardiovascular events (composite) | 64 (25.9) | 42 (28.2) | 0.620 |
| Recurrent stroke | 48 (19.4) | 27 (18.1) | 0.747 | |
| Myocardial infarction | 12 (4.9) | 8 (5.4) | 0.822 | |
| Vascular death | 14 (5.7) | 11 (7.4) | 0.497 | |
| Patients group | Event | Education | Events N (%) |
Unadjusted HR (95% CI) |
Model 1 HR (95% CI) |
Model 2 HR (95% CI) |
Model 3 HR (95% CI) |
|---|---|---|---|---|---|---|---|
| p | p | p | p | ||||
| ACS | MACE | Lower | 267/578 (46.2) | Ref | Ref | Ref | Ref |
| Higher | 179/574 (31.2) | 0.57 (0.47-0.69) | 0.85 (0.68-1.06) | 0.91 (0.73-1.14) | 0.90 (0.72-1.12) | ||
| <0.001‡ | 0.145 | 0.424 | 0.327 | ||||
| All-cause mortality | Lower | 138/578 (23.9) | Ref | Ref | Ref | Ref | |
| Higher | 73/574 (12.7) | 0.48 (0.36-0.64) | 0.86 (0.62-1.19) | 0.98 (0.71-1.36) | 0.96 (0.69-1.34) | ||
| <0.001‡ | 0.368 | 0.907 | 0.824 | ||||
| Cardiac death | Lower | 70/578 (12.1) | Ref | Ref | Ref | Ref | |
| Higher | 41/574 (7.1) | 0.54 (0.37-0.79) | 0.89 (0.57-1.39) | 1.07 (0.68-1.69) | 1.08 (0.68-1.71) | ||
| 0.002† | 0.608 | 0.776 | 0.744 | ||||
| Recurrent MI | Lower | 62/578 (10.7) | Ref | Ref | Ref | Ref | |
| Higher | 48/574 (8.4) | 0.64 (0.44-0.93) | 0.74 (0.48-1.15) | 0.83 (0.53-1.30) | 0.78 (0.50-1.22) | ||
| 0.021* | 0.187 | 0.422 | 0.227 | ||||
| Recurrent percutaneous coronary intervention | Lower | 92/578 (15.9) | Ref | Ref | Ref | Ref | |
| Higher | 70/574 (12.2) | 0.69 (0.50-0.94) | 0.84 (0.58-1.21) | 0.91 (0.63-1.31) | 0.89 (0.62-1.29) | ||
| 0.017* | 0.345 | 0.623 | 0.537 | ||||
| Stroke | Composite CCVEs | Lower | 64/247 (25.9) | Ref | Ref | Ref | Ref |
| Higher | 42/149 (28.2) | 1.11 (0.75-1.63) | 1.09 (0.70-1.69) | 1.10 (0.71-1.72) | 1.06 (0.68-1.66) | ||
| 0.613 | 0.717 | 0.671 | 0.805 | ||||
| Recurrent stroke | Lower | 48/247 (19.4) | Ref | Ref | Ref | Ref | |
| Higher | 27/149 (18.1) | 0.95 (0.59-1.52) | 1.06 (0.62-1.82) | 1.05 (0.61-1.80) | 1.03 (0.60-1.78) | ||
| 0.834 | 0.832 | 0.862 | 0.918 | ||||
| Myocardial infarction | Lower | 12/247 (4.9) | Ref | Ref | Ref | Ref | |
| Higher | 8/149 (5.4) | 1.11 (0.45-2.71) | 0.65 (0.25-1.70) | 0.73 (0.28-1.96) | 0.64 (0.23-1.76) | ||
| 0.820 | 0.378 | 0.536 | 0.386 | ||||
| Vascular death | Lower | 14/247 (5.7) | Ref | Ref | Ref | Ref | |
| Higher | 11/149 (7.4) | 1.33 (0.60-2.92) | 1.07 (0.45-2.60) | 1.25 (0.51-3.09) | 1.19 (0.47-2.98) | ||
| 0.486 | 0.877 | 0.622 | 0.717 |
Model 1: adjusted for age, sex, and vascular risk factors (hypertension, diabetes, hypercholesterolemia, obesity, smoking, previous and family history of ACS; hypercholesterolemia, cardiac disease and smoking for stroke). Model 2: adjusted for age, sex, and psychiatric/sociodemographic/disease severity factors (living alone, housing, employment, life stressors, depression comorbidity and treatment status, prior depression, ACS diagnosis, Killip class, LVEF, troponin I, CK-MB for ACS; living alone, life stressors, NIHSS, DSM-IV depression, prior depression for stroke). Model 3: fully adjusted model combining all covariates from Models 1 and 2.
HR, harard ratio; CI, confidence interval; ACS, acute coronary syndrome; MACE, major adverse cardiac events; MI, myocardial infarction; CCVE, cerebro-cardiovascular events; LVEF, left ventricular ejection fraction; CK-MB, creatine kinase-MB; NIHSS, National Institutes of Health Stroke Scale; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, Forth Edition.

![]() |
![]() |